• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7132
Medical Device Problem Codes Break (1069); Difficult to Remove (1528); Difficult to Advance (2920)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/30/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that shaft break and removal difficulties occurred, requiring surgery.The patient presented with coronary artery disease and underwent percutaneous coronary intervention.The target lesion was 70% stenosed, severely tortuous, and moderately calcified.After two stents were deployed separately at the bifurcation, situated from the left main into the left anterior descending artery and left circumflex, a 2.50mm x 12mm emerge balloon catheter was advanced to cross the side branch through a stent strut.However, the shaft broke 9 cm from the distal tip and was left distal through the stent strut.A snare was advanced, but due to tortuosity coupled with the stent struts, retrieval of the device was extremely difficult.The patient remained in stable condition with no abnormalities in pressure despite the balloon being stuck.After considering catheter-based options for retrieval, the physician decided to send the patient to open heart surgery to extract the balloon before the patient became unstable.The fractured device was removed in open heart surgery with no damage observed on the implanted stent, and the procedure was completed.The patient fully recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18769226
Report Number2124215-2024-07347
Device Sequence Number4462652
Product Code LOX
UDI-Device Identifier08714729806103
UDI-Public08714729806103
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K113220
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/15/2026
Device Model Number7132
Device Catalogue Number7132
Device Lot Number0032207886
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/31/2024
Initial Report FDA Received Date02/23/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/14/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-